Development of innovative therapeutic and diagnostic solutions to treat therapeutic resistance and metastasis evolution, with a focus on precision medicine.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: May 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
Transgene
A
Development of innovative immunotherapies against cancer using advanced genetic engineering and artificial intelligence technologies.
Priothera
B
Development of innovative therapies for hematological malignancies, focusing on immune modulators to enhance outcomes in allogeneic hematopoietic cell transplantation and CAR T cell therapy.
Sanofi
B
Development of innovative medicines and vaccines to improve patients' lives, focusing on areas like immunology, oncology, rare diseases, and vaccines.
Initiatives identified among leaders
Unité de santé mondiale
“L'unité de santé mondiale de Sanofi pasteur fourni...” - SanofiAlignement avec les objectifs de développement durable
“Transgene s'aligne avec les objectifs de développe...” - TransgeneParticipation à la course de la ville de Bâle
“Priothera développe des thérapies innovantes pour ...” - Priothera42% of similar organizations communicate on CSR issues
+260 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports